BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ACORDA THERAPEUTICS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Termination

ACORDA THERAPEUTICS, INC.

via FABIANI & COMPANY

4th Quarter (Oct 1 - Dec 31) · 2013Posted Jan 23, 2014Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: ACORDA THERAPEUTICS, INC.
Description: Biotech company that focuses on therapies to restore neurological functions
Location: New York · United States of America

Registrant

Firm: FABIANI & COMPANY
Description: Global trade
Location: Washington, District of Columbia, United States of America

Lobbying activities

2 issues

Budget/Appropriations
Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research.
LobbyistsSCOTT TOMINOVICH
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)
Medical/Disease Research/Clinical Labs
Educate staff about Acordas products and research interests.
LobbyistsSCOTT TOMINOVICH
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.